Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3410 | 1597 | 49.0 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
3410 | 2 | ZEBRAFISH//FACTOR VII ACTIVATING PROTEASE//FSAP | 1597 |
7337 | 1 | ZEBRAFISH//MED ZEBRAFISH//FISH EMBRYO TEST | 1379 |
34458 | 1 | FSAP//FACTOR VII ACTIVATING PROTEASE//PLASMA HYALURONAN BINDING PROTEIN | 111 |
34765 | 1 | BROWN TROUT FARMING//DIL C18//IN VIVO THROMBOSIS MODEL | 107 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ZEBRAFISH | authKW | 635494 | 32% | 7% | 511 |
2 | FACTOR VII ACTIVATING PROTEASE | authKW | 309720 | 1% | 90% | 18 |
3 | FSAP | authKW | 294970 | 1% | 86% | 18 |
4 | PLASMA HYALURONAN BINDING PROTEIN | authKW | 173805 | 1% | 91% | 10 |
5 | PHBP | authKW | 172069 | 1% | 100% | 9 |
6 | MARBURG I POLYMORPHISM | authKW | 114712 | 0% | 100% | 6 |
7 | HABP2 | authKW | 93678 | 0% | 70% | 7 |
8 | MED ZEBRAFISH | address | 82607 | 1% | 39% | 11 |
9 | FISH EMBRYO TEST | authKW | 81497 | 1% | 47% | 9 |
10 | FACTOR VII ACTIVATING PROTEASE FSAP | authKW | 79660 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Developmental Biology | 8208 | 15% | 0% | 234 |
2 | Cell Biology | 1824 | 19% | 0% | 299 |
3 | Hematology | 1711 | 11% | 0% | 170 |
4 | Toxicology | 1363 | 9% | 0% | 150 |
5 | Zoology | 529 | 7% | 0% | 108 |
6 | Biochemistry & Molecular Biology | 320 | 16% | 0% | 256 |
7 | Biochemical Research Methods | 319 | 6% | 0% | 90 |
8 | Pathology | 303 | 5% | 0% | 73 |
9 | Fisheries | 229 | 3% | 0% | 43 |
10 | Multidisciplinary Sciences | 224 | 2% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED ZEBRAFISH | 82607 | 1% | 39% | 11 |
2 | MOL CELLULAR PHARMACOL PHARMACOGEN PHARM | 67969 | 1% | 44% | 8 |
3 | OMICS MED | 67969 | 1% | 44% | 8 |
4 | MRC DEV BIOMED GENET | 53615 | 1% | 17% | 17 |
5 | IND TECHNOL INNOVAT | 49943 | 1% | 29% | 9 |
6 | BIOANALYT ECOTOXICOL | 48017 | 1% | 15% | 17 |
7 | STEM CELL PROGRAM HEMATOL ONCOL | 43697 | 0% | 57% | 4 |
8 | STEM CELL PROGRAM | 40865 | 2% | 6% | 34 |
9 | COMPLEX SYST SIGNAL PROC GRP | 38237 | 0% | 100% | 2 |
10 | DADE BEHRING MARBURG GMBH | 38237 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ZEBRAFISH | 209414 | 5% | 14% | 76 |
2 | DISEASE MODELS & MECHANISMS | 45355 | 3% | 5% | 45 |
3 | BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS | 7611 | 1% | 4% | 9 |
4 | METHODS IN CELL BIOLOGY | 5645 | 2% | 1% | 27 |
5 | BLOOD CELLS MOLECULES AND DISEASES | 3857 | 1% | 1% | 19 |
6 | JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 3405 | 2% | 1% | 28 |
7 | REPRODUCTIVE TOXICOLOGY | 3012 | 1% | 1% | 20 |
8 | DEVELOPMENTAL DYNAMICS | 1301 | 1% | 0% | 18 |
9 | DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY | 1025 | 1% | 0% | 14 |
10 | EXPERT OPINION ON DRUG DISCOVERY | 928 | 0% | 1% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZEBRAFISH | 635494 | 32% | 7% | 511 | Search ZEBRAFISH | Search ZEBRAFISH |
2 | FACTOR VII ACTIVATING PROTEASE | 309720 | 1% | 90% | 18 | Search FACTOR+VII+ACTIVATING+PROTEASE | Search FACTOR+VII+ACTIVATING+PROTEASE |
3 | FSAP | 294970 | 1% | 86% | 18 | Search FSAP | Search FSAP |
4 | PLASMA HYALURONAN BINDING PROTEIN | 173805 | 1% | 91% | 10 | Search PLASMA+HYALURONAN+BINDING+PROTEIN | Search PLASMA+HYALURONAN+BINDING+PROTEIN |
5 | PHBP | 172069 | 1% | 100% | 9 | Search PHBP | Search PHBP |
6 | MARBURG I POLYMORPHISM | 114712 | 0% | 100% | 6 | Search MARBURG+I+POLYMORPHISM | Search MARBURG+I+POLYMORPHISM |
7 | HABP2 | 93678 | 0% | 70% | 7 | Search HABP2 | Search HABP2 |
8 | FISH EMBRYO TEST | 81497 | 1% | 47% | 9 | Search FISH+EMBRYO+TEST | Search FISH+EMBRYO+TEST |
9 | FACTOR VII ACTIVATING PROTEASE FSAP | 79660 | 0% | 83% | 5 | Search FACTOR+VII+ACTIVATING+PROTEASE+FSAP | Search FACTOR+VII+ACTIVATING+PROTEASE+FSAP |
10 | FACTOR SEVEN ACTIVATING PROTEASE | 76475 | 0% | 100% | 4 | Search FACTOR+SEVEN+ACTIVATING+PROTEASE | Search FACTOR+SEVEN+ACTIVATING+PROTEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAN DER ENT, W , VENEMAN, WJ , GROENEWOUD, A , CHEN, LP , TULOTTA, C , HOGENDOORN, PCW , SPAINK, HP , SNAAR-JAGALSKA, BE , (2016) AUTOMATION OF TECHNOLOGY FOR CANCER RESEARCH.CANCER AND ZEBRAFISH: MECHANISMS, TECHNIQUES, AND MODELS. VOL. 916. ISSUE . P. 315 -332 | 55 | 85% | 1 |
2 | WHITE, R , ROSE, K , ZON, L , (2013) ZEBRAFISH CANCER: THE STATE OF THE ART AND THE PATH FORWARD.NATURE REVIEWS CANCER. VOL. 13. ISSUE 9. P. 624-636 | 59 | 54% | 84 |
3 | DANG, M , FOGLEY, R , ZON, LI , (2016) IDENTIFYING NOVEL CANCER THERAPIES USING CHEMICAL GENETICS AND ZEBRAFISH.CANCER AND ZEBRAFISH: MECHANISMS, TECHNIQUES, AND MODELS. VOL. 916. ISSUE . P. 103 -124 | 51 | 69% | 2 |
4 | VEINOTTE, CJ , DELLAIRE, G , BERMAN, JN , (2014) HOOKING THE BIG ONE: THE POTENTIAL OF ZEBRAFISH XENOTRANSPLANTATION TO REFORM CANCER DRUG SCREENING IN THE GENOMIC ERA.DISEASE MODELS & MECHANISMS. VOL. 7. ISSUE 7. P. 745 -754 | 54 | 60% | 20 |
5 | MIONE, MC , TREDE, NS , (2010) THE ZEBRAFISH AS A MODEL FOR CANCER.DISEASE MODELS & MECHANISMS. VOL. 3. ISSUE 9-10. P. 517 -523 | 45 | 82% | 37 |
6 | VITTORI, M , MOTALN, H , TURNSEK, TL , (2015) THE STUDY OF GLIOMA BY XENOTRANSPLANTATION IN ZEBRAFISH EARLY LIFE STAGES.JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. VOL. 63. ISSUE 10. P. 749 -761 | 52 | 66% | 3 |
7 | XIE, XY , ROSS, JL , COWELL, JK , TENG, Y , (2015) THE PROMISE OF ZEBRAFISH AS A CHEMICAL SCREENING TOOL IN CANCER THERAPY.FUTURE MEDICINAL CHEMISTRY. VOL. 7. ISSUE 11. P. 1395 -1405 | 51 | 67% | 2 |
8 | ZHANG, BB , XUAN, C , JI, YX , ZHANG, WM , WANG, DG , (2015) ZEBRAFISH XENOTRANSPLANTATION AS A TOOL FOR IN VIVO CANCER STUDY.FAMILIAL CANCER. VOL. 14. ISSUE 3. P. 487 -493 | 44 | 75% | 3 |
9 | MATHIAS, JR , SAXENA, MT , MUMM, JS , (2012) ADVANCES IN ZEBRAFISH CHEMICAL SCREENING TECHNOLOGIES.FUTURE MEDICINAL CHEMISTRY. VOL. 4. ISSUE 14. P. 1811-1822 | 49 | 64% | 25 |
10 | CEOL, CJ , HOUVRAS, Y , (2016) UNCHARTED WATERS: ZEBRAFISH CANCER MODELS NAVIGATE A COURSE FOR ONCOGENE DISCOVERY.CANCER AND ZEBRAFISH: MECHANISMS, TECHNIQUES, AND MODELS. VOL. 916. ISSUE . P. 3 -19 | 50 | 62% | 0 |
Classes with closest relation at Level 2 |